ID27820A - APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF - Google Patents

APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF

Info

Publication number
ID27820A
ID27820A IDW20001948A ID20001948A ID27820A ID 27820 A ID27820 A ID 27820A ID W20001948 A IDW20001948 A ID W20001948A ID 20001948 A ID20001948 A ID 20001948A ID 27820 A ID27820 A ID 27820A
Authority
ID
Indonesia
Prior art keywords
mflint
opg3
polipeptide
receptor
applications
Prior art date
Application number
IDW20001948A
Other languages
English (en)
Indonesian (id)
Inventor
Shenshen Nmm Dou
Ho Yeong Song
Songging Nmm Na
Andrew Lawrence Glasebrook
Timothy Wayne Noblitt
James Arthur Posada
Thomas Frank Bumol
Kenneth Elliot Gould
John Edward Hale
Josef Georg Heuer
Kwan Yuk Hui
Alexei Kharitonenkov
Jacques Mizrahi
Charles Arthur Reidy
Jian Wang
Xiying Wu
Steven Harold Zuckermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27820A publication Critical patent/ID27820A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20001948A 1998-03-30 1999-03-30 APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF ID27820A (id)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US7985698P 1998-03-30 1998-03-30
US8607498P 1998-05-20 1998-05-20
US9964398P 1998-09-09 1998-09-09
US11257798P 1998-12-17 1998-12-17
US11270398P 1998-12-18 1998-12-18
US11293398P 1998-12-18 1998-12-18
US11340798P 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ID27820A true ID27820A (id) 2001-04-26

Family

ID=27568394

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001948A ID27820A (id) 1998-03-30 1999-03-30 APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF

Country Status (16)

Country Link
US (1) US20040167074A1 (zh)
JP (1) JP2002512006A (zh)
KR (1) KR20010042364A (zh)
CN (1) CN1303429A (zh)
AU (1) AU3369199A (zh)
BR (1) BR9909328A (zh)
CA (1) CA2324517A1 (zh)
CZ (1) CZ20003433A3 (zh)
EA (1) EA200001004A1 (zh)
HU (1) HUP0102067A2 (zh)
ID (1) ID27820A (zh)
IL (1) IL138626A0 (zh)
NO (1) NO20004873L (zh)
PL (1) PL343847A1 (zh)
TR (1) TR200002824T2 (zh)
WO (1) WO1999050413A2 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247567A (zh) 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
DE69839401T2 (de) 1997-09-18 2009-05-07 Genentech Inc., San Francisco Dcr3 polypeptid, ein tnfr homolog
AU2211100A (en) * 1998-12-22 2000-07-12 Eli Lilly And Company Therapeutic applications of flint polypeptides
JP4590504B2 (ja) * 1999-03-30 2010-12-01 イーライ リリー アンド カンパニー プロテアーゼ耐性ｆｌｉｎｔ類似体
US6627199B1 (en) 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
CA2381284A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Fhm, a novel member of the tnf ligand supergene family
WO2001010908A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
WO2001018041A2 (en) * 1999-09-10 2001-03-15 Eli Lilly And Company Flint proteins and formulations thereof
AU1189101A (en) * 1999-10-20 2001-04-30 Eli Lilly And Company Therapeutic applications of flint polypeptides
EP1244783A1 (en) * 1999-12-07 2002-10-02 Eli Lilly And Company Improving stability of flint through o-linked glycosylation
AU2001286688A1 (en) * 2000-08-25 2002-03-13 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6alpha and 6beta
EP1364653A4 (en) * 2001-02-23 2005-01-26 Takeda Pharmaceutical CASOASE-3 INHIBITORS
SI1606318T1 (sl) 2003-03-26 2009-12-31 Apogenix Gmbh Izboljšani Fc fuzijski proteini
EP1841442A4 (en) * 2005-01-07 2009-12-09 Northern Sydney And Central Co TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
PL2428252T3 (pl) 2006-12-28 2015-04-30 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Neutralizacja aktywności cd95 blokuje inwazję komórek glejaka in vivo
JP5665739B2 (ja) * 2008-07-14 2015-02-04 ドイチェス クレープスフォルシュングスツェントルムＤｅｕｔｓｃｈｅｓ Ｋｒｅｂｓｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ 炎症性疾患を治療するためのｃｄ９５インヒビターの使用
CN102671186B (zh) * 2011-09-19 2014-08-06 上海市肿瘤研究所 促造血的药物组合物及其应用
ES2589134T3 (es) 2012-07-18 2016-11-10 Apogenix Ag Inhibidores de la ruta de señalización de CD95 para el tratamiento de MDS
EP3076179A1 (en) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnosis and treatment of low grade gliomas
TWI623321B (zh) 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
JP6793748B2 (ja) * 2015-12-18 2020-12-02 タレンゲン インターナショナル リミテッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ 放射性および化学的損傷を予防及び治療するための方法
AU2020256125A1 (en) 2019-03-29 2021-11-18 Turnstone Biologics Corp. Ex vivo methods for producing a T cell therapeutic and related compositions and methods
AU2020391231A1 (en) 2019-11-27 2022-07-14 Turnstone Biologics Corp. Method of producing tumor-reactive T cell composition using modulatory agents
MX2022010517A (es) 2020-02-27 2022-11-14 Myst Therapeutics Llc Metodos para la expansion y enriquecimiento ex vivo de celulas t reactivas a tumor y composiciones relacionadas de las mismas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247567A (zh) * 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
WO1999004001A1 (en) * 1997-07-21 1999-01-28 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-5
JP2001512667A (ja) * 1997-08-06 2001-08-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトオーファンレセプターｎｔｒ−１
DE69839401T2 (de) * 1997-09-18 2009-05-07 Genentech Inc., San Francisco Dcr3 polypeptid, ein tnfr homolog
AU1535699A (en) * 1997-11-24 1999-06-15 Apotech S.A. Novel receptors opg-2

Also Published As

Publication number Publication date
WO1999050413A3 (en) 1999-12-02
WO1999050413A2 (en) 1999-10-07
PL343847A1 (en) 2001-09-10
JP2002512006A (ja) 2002-04-23
CA2324517A1 (en) 1999-10-07
CZ20003433A3 (cs) 2001-10-17
IL138626A0 (en) 2001-10-31
KR20010042364A (ko) 2001-05-25
AU3369199A (en) 1999-10-18
US20040167074A1 (en) 2004-08-26
NO20004873L (no) 2000-11-24
HUP0102067A2 (hu) 2001-10-28
CN1303429A (zh) 2001-07-11
NO20004873D0 (no) 2000-09-28
BR9909328A (pt) 2000-12-12
TR200002824T2 (tr) 2000-12-21
EA200001004A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
ID27820A (id) APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF
BRPI0010891B1 (pt) geração de microespuma terapêutica.
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DE69902758D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivative
DE59701304D1 (de) Wirbelsäulenorthese
IT238006Y1 (it) Dispositivo massaggiatore,ad elevata semplicita' strutturale,utilizzabile direttamente o inseribile all'interno dello schienale
DE69930330D1 (de) Durchlaufwärmebehandlungsofen
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
NO20000456D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan
EP1117675A4 (en) THE KADHERING SIMILAR PROTEIN AND METHOD FOR ITS MANUFACTURE
ID26368A (id) Turunan-turunan 2 deoksi higromisin
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
FR2721203B1 (fr) Orthèse du membre inférieur.
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
ITMI992457A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
NO20012301D0 (no) Ny fremgangsmåte for behandling
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
DK0994849T3 (da) Fremgangsmåde til fremstilling af 2,4,5-triflour-benzonitril
IT1308677B1 (it) Procedimento per produrre 2,2,6,6-tetrametil-4-piperidone
ITMI970682A1 (it) Procedimento per la preparazione di (s)-n-terbutil-1, 2, 3, 4- tetraidroisochinolin-3- carbossiammide